There is no viable substitute for re-energizing, funding and supporting culturally attuned, locally staffed HIV advocacy and prevention programmes, especially in resource poor settings. The evidence that such interventions are effective remains compelling; and although the cost implications are not negligible, the medium to long-term outcomes must be regarded not as complementary, but as integr...

Clinical findings about the adverse effects of use antiretroviral drugs in oral cavity people with HIV / AIDS began to be found. A case regarding side is discovery lesions form whitish plaque on lips and right buccal mucosa that has occurred more than one month accompanied by complaints taste disorders, xerostomia, a burning feeling patients using Nevirapine, Zidovudine Lamivudine. This study w...

Purpose: To document the utilization of traditional medicines in managing human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) opportunistic infections in sub-Saharan Africa. Methods: This study is based on a review of literature published in scientific journals, books, reports from national, regional and international organizations, theses and conference papers obtained f...

The human immunodeficiency virus type 1 (HIV-1) is the causative agent of one of the most dangerous human diseases - the acquired immune deficiency syndrome (AIDS). Over the past 30 years since the discovery of HIV-1, a number of antiviral drugs have been developed to suppress various stages of the HIV-1 life cycle. This approach has enables the suppression of virus replication in the body, whi...

Tuberculosis is an infectious disease caused by Mycobacterium tuberculosis. Globally, tuberculosis is second only to AIDS in mortality and the disease is responsible for over 1.3 million deaths each year. The impractically long treatment schedules (generally 6-9 months) and unpleasant side effects of the current drugs often lead to poor patient compliance, which in turn has resulted in the emer...